HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differential regulation patterns of the anti-CD20 antibodies obinutuzumab and rituximab in mantle cell lymphoma.

AuthorsDaniel A Heinrich, Marc Weinkauf, Grit Hutter, Yvonne Zimmermann, Vindi Jurinovic, Wolfgang Hiddemann, Martin Dreyling
JournalBritish journal of haematology (Br J Haematol) Vol. 168 Issue 4 Pg. 606-10 (Feb 2015) ISSN: 1365-2141 [Electronic] England
PMID25292485 (Publication Type: Comparative Study, Letter)
Chemical References
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20
  • Neoplasm Proteins
  • Rituximab
  • obinutuzumab
Topics
  • Antibodies, Monoclonal, Humanized (administration & dosage, immunology, pharmacology, therapeutic use)
  • Antibodies, Monoclonal, Murine-Derived (administration & dosage, immunology, pharmacology, therapeutic use)
  • Antibody Specificity
  • Antigens, CD20 (immunology)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Cell Line, Tumor
  • Drug Synergism
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Humans
  • In Vitro Techniques
  • Lymphoma, Mantle-Cell (drug therapy, pathology)
  • Neoplasm Proteins (biosynthesis, genetics)
  • Rituximab

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: